Anna Szałek-Goralewska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Szałek-Goralewska has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Rafał Dankowski
Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland
2 shared publications - Wioletta Sacharczuk
2nd Department of Cardiology, Poznan University of Medical Sciences, Poland
2 shared publications - Andrzej Szyszka
2nd Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland
1 shared publication - Anna Marciniak
Department of Cardiology, St George’s University Hospitals NHS Foundation Trust , Blackshaw Road, Tooting, London SW17 0QT, UK
1 shared publication - Artur Baszko
Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland
1 shared publication Dagmara Tritt
Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland
1 shared publication
Latest Publications
- Open Access
- 24 October 2026
- Published by Springer Nature in European Journal of Applied Physiology
- p. 1-10
The ascending aorta and vascular profile in recreational masters runners: a cross-sectional study
Purpose: Endurance exercise remodels the large arteries, but whether a recreational training dose is sufficient to induce such remodelling is unclear. Masters recreational runners over 40 years are under-represented in this research. We compared the ascending aortic diameter and vascular profile of these runners with sedentary controls of similar age. Methods: This cross-sectional study included 42 masters recreational runners (at least 20 km per week for at least one year) and 27 sedentary controls, all over 40 years, free of cardiovascular disease and without bicuspid aortic valve or connective tissue disorder. We measured the ascending aortic diameter and left ventricular function by transthoracic echocardiography, and brachial-ankle pulse wave velocity (baPWV) and the ankle-brachial index (ABI) by oscillometry. Circulating collagen-turnover markers (CTX-I, MMP-2) were assayed. The aortic diameter was compared between groups by regression. Results: The ascending aorta was wider in runners (3.25 vs. 2.90 cm; p = 0.001; Cliff’s delta 0.45). The difference persisted after adjustment for age, sex and height (beta 0.31 cm; p = 0.001) and in sensitivity analyses. No aortic diameter reached 4.0 cm; all remained within normal limits. The ABI was higher in runners (1.07 vs. 1.03; p = 0.007), and baPWV did not differ ( p = 0.069); both stayed within normal limits. CTX-I and MMP-2 did not differ, and left ventricular function was preserved. Conclusion: These findings are consistent with modest, exercise-associated aortic remodelling rather than overt aortopathy in recreational masters runners over 40 years.
- 24 October 2026
- Published by Springer Nature in European Journal of Applied Physiology
- p. 1-10
Open AccessThe ascending aorta and vascular profile in recreational masters runners: a cross-sectional study
Purpose: Endurance exercise remodels the large arteries, but whether a recreational training dose is sufficient to induce such remodelling is unclear. Masters recreational runners over 40 years are under-represented in this research. We compared the ascending aortic diameter and vascular profile of these runners with sedentary controls of similar age. Methods: This cross-sectional study included 42 masters recreational runners (at least 20 km per week for at least one year) and 27 sedentary controls, all over 40 years, free of cardiovascular disease and without bicuspid aortic valve or connective tissue disorder. We measured the ascending aortic diameter and left ventricular function by transthoracic echocardiography, and brachial-ankle pulse wave velocity (baPWV) and the ankle-brachial index (ABI) by oscillometry. Circulating collagen-turnover markers (CTX-I, MMP-2) were assayed. The aortic diameter was compared between groups by regression. Results: The ascending aorta was wider in runners (3.25 vs. 2.90 cm; p = 0.001; Cliff’s delta 0.45). The difference persisted after adjustment for age, sex and height (beta 0.31 cm; p = 0.001) and in sensitivity analyses. No aortic diameter reached 4.0 cm; all remained within normal limits. The ABI was higher in runners (1.07 vs. 1.03; p = 0.007), and baPWV did not differ ( p = 0.069); both stayed within normal limits. CTX-I and MMP-2 did not differ, and left ventricular function was preserved. Conclusion: These findings are consistent with modest, exercise-associated aortic remodelling rather than overt aortopathy in recreational masters runners over 40 years.
- Open Access
- 28 September 2021
- Published by Poznan University of Medical Sciences in Journal of Medical Science
- Vol. 90 (3) , e532
Cardiovascular imaging in the acute phase of coronavirus disease 2019 (COVID-19)
The coronavirus disease 2019 (COVID-19) has become the most critical healthcare issue worldwide since the pandemic was announced in March 2020. Although respiratory symptoms remain the critical characteristic feature of COVID-19 (with acute respiratory syndrome as the leading cause of mortality), the disease also affects other organs. In fact, the involvement of the cardiovascular system during COVID-19 may include acute coronary symptoms, acute heart failure and myocarditis, arrhythmias, cardiac tamponade, pulmonary embolism, and right ventricular failure due to a high-pressure mechanical ventilation. It is vital to note that all of the abovementioned disorders require specific, pandemic-adapted imaging algorithms. This brief review aims to discuss different cardiac imaging modalities to demonstrate their effectiveness in managing patients in the acute phase of COVID-19.
- 28 September 2021
- Published by Poznan University of Medical Sciences in Journal of Medical Science
- Vol. 90 (3) , e532
Open AccessCardiovascular imaging in the acute phase of coronavirus disease 2019 (COVID-19)
The coronavirus disease 2019 (COVID-19) has become the most critical healthcare issue worldwide since the pandemic was announced in March 2020. Although respiratory symptoms remain the critical characteristic feature of COVID-19 (with acute respiratory syndrome as the leading cause of mortality), the disease also affects other organs. In fact, the involvement of the cardiovascular system during COVID-19 may include acute coronary symptoms, acute heart failure and myocarditis, arrhythmias, cardiac tamponade, pulmonary embolism, and right ventricular failure due to a high-pressure mechanical ventilation. It is vital to note that all of the abovementioned disorders require specific, pandemic-adapted imaging algorithms. This brief review aims to discuss different cardiac imaging modalities to demonstrate their effectiveness in managing patients in the acute phase of COVID-19.